{"id":"https://openalex.org/W159538443","doi":"https://doi.org/10.1177/106002808201600902","title":"Temazepam (Restoril, Sandoz Pharmaceuticals)","display_name":"Temazepam (Restoril, Sandoz Pharmaceuticals)","publication_year":1982,"publication_date":"1982-09-01","ids":{"openalex":"https://openalex.org/W159538443","doi":"https://doi.org/10.1177/106002808201600902","mag":"159538443","pmid":"https://pubmed.ncbi.nlm.nih.gov/6127197"},"language":"en","primary_location":{"id":"doi:10.1177/106002808201600902","doi":"https://doi.org/10.1177/106002808201600902","is_oa":false,"landing_page_url":"https://doi.org/10.1177/106002808201600902","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Intelligence &amp; Clinical Pharmacy","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010571477","display_name":"Eric A. Jackson","orcid":"https://orcid.org/0000-0001-7649-8261","observed_orcids":["https://orcid.org/0000-0001-7649-8261"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eric A. Jackson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104054140","display_name":"Alex A. Cardoni","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alex A. Cardoni","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108626306","display_name":"James C. McElnay","orcid":"https://orcid.org/0000-0002-1082-9715","observed_orcids":["https://orcid.org/0000-0002-1082-9715"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James C. McElnay","raw_affiliation_strings":["School of Pharmacy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mark E. Jones","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark E. Jones","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5010019881","display_name":"BRUCE K. ALEXANDER","orcid":"https://orcid.org/0000-0002-4090-2274","observed_orcids":["https://orcid.org/0000-0002-4090-2274"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bruce Alexander","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":164,"citation_normalized_percentile":{"value":0.03333333,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"16","issue":"9","first_page":"650","last_page":"656"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10316","display_name":"Sleep and related disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10316","display_name":"Sleep and related disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10436","display_name":"Anesthesia and Sedative Agents","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/temazepam","display_name":"temazepam","score":1.0},{"id":"https://openalex.org/keywords/benzodiazepine-hypnotics","display_name":"benzodiazepine hypnotics","score":0.8849999904632568},{"id":"https://openalex.org/keywords/insomnia-treatment","display_name":"insomnia treatment","score":0.878000020980835},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9829999804496765},{"id":"https://openalex.org/keywords/sleep-parameters","display_name":"sleep parameters","score":0.7129999995231628},{"id":"https://openalex.org/keywords/sleep-onset-latency","display_name":"sleep latency","score":0.8309999704360962},{"id":"https://openalex.org/keywords/comparative-efficacy","display_name":"drug efficacy comparison","score":0.43799999356269836},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.7210000157356262},{"id":"https://openalex.org/keywords/hangover-effects","display_name":"hangover effects","score":0.9459999799728394},{"id":"https://openalex.org/keywords/rebound-insomnia","display_name":"rebound insomnia","score":0.9610000252723694},{"id":"https://openalex.org/keywords/sleep-induction","display_name":"sleep induction","score":0.5189999938011169}],"concepts":[{"id":"https://openalex.org/C2781006864","wikidata":"https://www.wikidata.org/wiki/Q414796","display_name":"Temazepam","level":4,"score":0.9945959448814392},{"id":"https://openalex.org/C2776615572","wikidata":"https://www.wikidata.org/wiki/Q412299","display_name":"Oxazepam","level":4,"score":0.8720706105232239},{"id":"https://openalex.org/C2776156762","wikidata":"https://www.wikidata.org/wiki/Q418998","display_name":"Flurazepam","level":4,"score":0.855887770652771},{"id":"https://openalex.org/C2777207853","wikidata":"https://www.wikidata.org/wiki/Q410078","display_name":"Nitrazepam","level":3,"score":0.7430110573768616},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.7172651290893555},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6716914176940918},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.6281810998916626},{"id":"https://openalex.org/C2781210498","wikidata":"https://www.wikidata.org/wiki/Q1869874","display_name":"Insomnia","level":2,"score":0.5652012228965759},{"id":"https://openalex.org/C2779706987","wikidata":"https://www.wikidata.org/wiki/Q408265","display_name":"Lorazepam","level":2,"score":0.5505589842796326},{"id":"https://openalex.org/C2778519950","wikidata":"https://www.wikidata.org/wiki/Q422435","display_name":"Bromazepam","level":4,"score":0.48716065287590027},{"id":"https://openalex.org/C2780930544","wikidata":"https://www.wikidata.org/wiki/Q62962","display_name":"Hypnotic","level":2,"score":0.45752039551734924},{"id":"https://openalex.org/C2777123777","wikidata":"https://www.wikidata.org/wiki/Q218842","display_name":"Zolpidem","level":3,"score":0.45260822772979736},{"id":"https://openalex.org/C2776175493","wikidata":"https://www.wikidata.org/wiki/Q210402","display_name":"Diazepam","level":2,"score":0.4317762851715088},{"id":"https://openalex.org/C31094802","wikidata":"https://www.wikidata.org/wiki/Q7539756","display_name":"Sleep induction","level":3,"score":0.4227927327156067},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.26856958866119385},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1738741099834442},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012893","descriptor_name":"Sleep Wake Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013693","descriptor_name":"Temazepam","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013693","descriptor_name":"Temazepam","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013693","descriptor_name":"Temazepam","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013693","descriptor_name":"Temazepam","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013693","descriptor_name":"Temazepam","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013693","descriptor_name":"Temazepam","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1177/106002808201600902","doi":"https://doi.org/10.1177/106002808201600902","is_oa":false,"landing_page_url":"https://doi.org/10.1177/106002808201600902","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Intelligence &amp; Clinical Pharmacy","raw_type":"journal-article"},{"id":"pmid:6127197","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6127197","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug intelligence & clinical pharmacy","raw_type":"Journal Article"},{"id":"pmh:oai:pure.qub.ac.uk/portal:publications/6a967b11-a484-4836-adc2-8f615420810a","doi":null,"is_oa":false,"landing_page_url":"https://pure.qub.ac.uk/en/publications/6a967b11-a484-4836-adc2-8f615420810a","pdf_url":null,"source":{"id":"https://openalex.org/S4306402319","display_name":"Research Portal (Queen's University Belfast)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I126231945","host_organization_name":"Queen's University Belfast","host_organization_lineage":["https://openalex.org/I126231945"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"McElnay, J, Jones, M E & Alexander, B 1982, 'TEMAZEPAM (RESTORIL, SANDOZ PHARMACEUTICALS)', DRUG INTELLIGENCE & CLINICAL PHARMACY, vol. 16, pp. 650-656.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W4779657","https://openalex.org/W1511700544","https://openalex.org/W1512826705","https://openalex.org/W1735866188","https://openalex.org/W1822335644","https://openalex.org/W1966581042","https://openalex.org/W1987607889","https://openalex.org/W1998850363","https://openalex.org/W2002555198","https://openalex.org/W2003405064","https://openalex.org/W2010238031","https://openalex.org/W2022600005","https://openalex.org/W2025414991","https://openalex.org/W2028433275","https://openalex.org/W2031666449","https://openalex.org/W2033297585","https://openalex.org/W2047627227","https://openalex.org/W2047876579","https://openalex.org/W2050544826","https://openalex.org/W2060008915","https://openalex.org/W2067326845","https://openalex.org/W2071666651","https://openalex.org/W2075856382","https://openalex.org/W2077751566","https://openalex.org/W2085426657","https://openalex.org/W2088821269","https://openalex.org/W2130434401","https://openalex.org/W2130575259","https://openalex.org/W2136277022","https://openalex.org/W2159007105","https://openalex.org/W2170364044","https://openalex.org/W2182728549","https://openalex.org/W2183843953","https://openalex.org/W2282663490","https://openalex.org/W2333563485","https://openalex.org/W2405426820","https://openalex.org/W2474948719","https://openalex.org/W4233643509"],"related_works":["https://openalex.org/W2050544826","https://openalex.org/W2084981963","https://openalex.org/W2137784018","https://openalex.org/W2017906291","https://openalex.org/W2027523157","https://openalex.org/W2183843953","https://openalex.org/W1992305309","https://openalex.org/W2461357239","https://openalex.org/W18419112","https://openalex.org/W4205654280"],"abstract_inverted_index":{"Temazepam":[0,107],"is":[1,25,33,104],"a":[2],"benzodiazepine":[3,114],"derivative":[4],"indicated":[5],"for":[6],"the":[7,14,20,29,84,129],"treatment":[8],"of":[9,13,64,96,132],"insomnia.":[10],"Pharmacokinetic":[11],"studies":[12,38],"hard":[15],"capsule":[16],"formulation":[17],"indicate":[18],"that":[19,119],"mean":[21,30],"time":[22],"to":[23],"peak":[24],"2.99":[26],"hours":[27],"and":[28,74,92,101,128,134],"elimination":[31],"half-life":[32],"14.7":[34],"hours.":[35],"Sleep":[36],"laboratory":[37],"have":[39],"demonstrated":[40],"improvements":[41,53],"in":[42,54,83],"all":[43,55],"sleep":[44,47,56,59,125],"parameters":[45,57],"except":[46],"onset":[48,60],"latency.":[49,61],"Clinically,":[50],"patients":[51],"report":[52],"including":[58],"The":[62,94,116],"efficacy":[63],"temazepam":[65],"compares":[66],"favorably":[67],"with":[68,81,139],"barbiturates,":[69],"glutethimide,":[70],"nitrazepam,":[71],"lorazepam,":[72],"oxazepam,":[73],"flurazepam.":[75],"It":[76],"has":[77,108],"not":[78],"been":[79],"compared":[80,138],"diazepam":[82],"clinical":[85],"setting.":[86],"Side":[87],"effects":[88,98],"include":[89,123],"drowsiness,":[90],"dizziness,":[91],"lethargy.":[93],"incidence":[95,131],"hangover":[97,133],"from":[99],"15-":[100],"30-mg":[102],"doses":[103],"relatively":[105],"low.":[106],"no":[109],"proven":[110],"advantages":[111],"over":[112],"other":[113],"hypnotics.":[115],"major":[117],"issues":[118],"need":[120],"further":[121],"clarification":[122],"temazepam's":[124],"induction":[126],"properties":[127],"relative":[130],"rebound":[135],"insomnia":[136],"when":[137],"longer-acting":[140],"benzodiazepines.":[141]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2020,"cited_by_count":157},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}
